NCT03362177 2026-02-11
RECITE
Amgen
Phase 3 Completed
Clinical Trials
13 trialsNCT04457297 2026-01-21
ALTAIR
National Cancer Center Hospital East
Phase 3 Completed
NCT02753127 2023-11-15
CanStem303C
Sumitomo Pharma America, Inc.
Phase 3 Completed
NCT03674294 2023-02-08
CINV
Sun Yat-sen University
Phase 3 Completed
NCT02322593 2021-12-20
SOLAR
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT01996306 2019-01-08
AXEPT
Epidemiological and Clinical Research Information Network
Phase 3 Completed
NCT02664974 2016-01-27
Home Enteral Nutrition in Malnourished Patients With Gastrointestinal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 3 Completed
NCT01423799 2015-11-13
Neoimmune
Société des Produits Nestlé (SPN)
Phase 3 Completed
NCT01269567 2015-07-23
GRECCAR 5
University Hospital, Bordeaux
Phase 3 Completed
NCT00455247 2013-06-05
Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects
Société des Produits Nestlé (SPN)
Phase 3 Completed
NCT00513357 2012-12-11
Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00052962 2012-11-22
Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT00798447 2011-06-09
Efficacy and Safety of a PN Regimen Containing n-3 Fatty Acid in Patients Considered After GI Surgery
B. Braun Melsungen AG
Phase 3 Completed